Calendar GRI BIOPAR

Equities

Market Closed - Nasdaq Other stock markets 02:00:00 30/04/2024 am IST			5-day change	1st Jan Change
0.4301 ^USD	+0.02%		-6.50%	-93.58%

16/04	GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments	MT
2023	Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

69f.gjhe6zLXteaS50uXaA_PLJJUbrBEyYdgqQtHDmn51h8.-38WqVWn6pfRshKmHWyWQuoBDOou-MUQ_TMsXCfLiVHEd2qjQa3lrtSqCg~90ea051d8f9bf38e1c401253fa01a855

No events available

17/01/2023 11:30 pm	Virtual Investor Companies to Watch Event
14/12/2022 07:00 pm	Vallon Pharmaceuticals and GRI Bio, Inc Merger Call
28/07/2022 05:30 pm	Interim 2022 Earnings Release
10/05/2022 01:35 am	Q1 2022 Earnings Release
23/03/2022 06:30 pm	Neuroscience Innovation Forum - Panel
15/02/2022 02:45 am	FY 2021 Earnings Release
25/01/2022 07:30 pm	JTC Team Virtual Investor Top Picks Conference
14/01/2022	APSARD Conference
10/01/2022 05:30 pm	H.C. Wainwright BioConnect Conference
19/11/2021 01:30 am	Virtual Investor Roundtable Event
15/11/2021 07:00 pm	H.C. Wainwright Virtual Conference
12/11/2021 06:35 pm	Q3 2021 Earnings Release
18/10/2021	American Academy of Child and Adolescent Psychiatry Meeting
18/08/2021 10:00 pm	Q3 Virtual Investor Summit
10/08/2021 05:35 pm	Interim 2021 Earnings Release
19/05/2021 01:45 am	Interim Virtual Investor Summit
13/05/2021 06:45 pm	Q1 2021 Earnings Release
29/04/2021 08:00 pm	Neuroscience Innovation Forum - Panel
29/03/2021 05:35 pm	FY 2020 Earnings Release
09/03/2021 05:30 pm	H.C. Wainwright Global Life Science Conference

Fiscal Period	December	2020	2021
Net sales Million USD	Released Forecast Spread	0,10	0,00 0,00 -
EBITDA	Released Forecast Spread	0,00	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	0,00	-9,26 -7,67 -20.8%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00	-9,30 -7,71 -20.71%
Net income Million USD	Released Forecast Spread	-4,82	-9,30 -7,71 -20.71%
EPS USD	Released Forecast Spread	-32,1	-42,6 -35,4 -20.34%
Announcement Date		29/03/21	14/02/22

Fiscal Period	December	2021 Q3	2021 Q4	2022 Q1	2022 Q2
Net sales Million USD	Released Forecast Spread		0,00 0,00 -	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread		-3,09 -1,50 -106.27%	-2,63 -1,90 -38.63%	-1,51 -2,45 38.53%
Earnings before Tax (EBT) Million USD	Released Forecast Spread		-3,10 -1,50 -106.4%	-2,64 -1,90 -38.68%	-1,77 -2,45 27.63%
Net income Million USD	Released Forecast Spread	-1,26	-3,10 -1,50 -106.4%	-2,64 -1,90 -38.68%	-1,77 -2,45 27.63%
EPS USD	Released Forecast Spread	-5,40	-13,8 -6,60 -109.09%	-11,7 -6,60 -77.27%	-6,00 -6,90 13.04%
Announcement Date		12/11/21	14/02/22	09/05/22	28/07/22